Also think this latest PR is just generally saying they will have the funds shortly (once the sale officially goes three) to complete the final data collection multi-month (many months) process to end the trial — investors have patience, no more raises, trial starts and trial ends are both going to happen.
Hi Flipper . I think you are right! The problem is that BP can see that unless datalock and unblinding occur at the start of 2019, we do not have enough money for the whole process. She needs to give a time for datalock to put Real pressure on BP. IMO
That's how I see it too. The leverage BP may have had over NWBO has weakened considerably. NWBO is now in a stronger position to negotiate a real deal. Cheers!
Just trying to jump into LP's shoes for a second. The simplest Occam's razor thinking I can establish, is that she would be thinking this latest move tells pharma "we are not financially desperate" to see this trial through. Clearly she thinks this probably would eliminate low ball offers, and place pharma on notice that the trial will be properly completed and a BLA likely filed without needing to look for funds. It's up to pharma whether they want to get serious before final results come in. imho.
I'm bullish. Things always take longer than we would like, but I really like our current position, Phase III/Cancer platform starting with L, blinded data, ... and runway cash.